We appreciate the comments made by Debourdeau et al. [
[1]
] regarding our recent publication “Incidence, risk factors, and evolution of venous
thromboembolic events in patients diagnosed with pancreatic carcinoma and treated
with chemotherapy on an outpatient basis” [
- Debourdeau P.
- Launay S.
- Chaouche M.
Which events to consider in the study of venous thromboses in pancreatic cancer patients?.
Eur J Intern Med. 2022; S0953-6205 (00407-1)https://doi.org/10.1016/j.ejim.2022.11.017
[2]
].To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Internal MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Which events to consider in the study of venous thromboses in pancreatic cancer patients?.Eur J Intern Med. 2022; S0953-6205 (00407-1)https://doi.org/10.1016/j.ejim.2022.11.017
- Incidence, risk factors, and evolution of venous thromboembolic events in patients diagnosed with pancreatic carcinoma and treated with chemotherapy on an outpatient basis.Eur J Intern Med. 2022; 105: 30-37https://doi.org/10.1016/j.ejim.2022.07.020
- Clinical outcome of patients with upper-extremity deep vein thrombosis: results from the RIETE Registry.Chest. 2008; 133: 143-148https://doi.org/10.1378/chest.07-1432
- BACAP Consortium. Incidence of Venous Thromboembolism in Patients With Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes.Gastroenterology. 2020; 158 (e4): 1346-1358https://doi.org/10.1053/j.gastro.2019.12.009
- Preventing Venous Thromboembolism in Patients with Cancer. Reply.N Engl J Med. 2019; 380: 2181https://doi.org/10.1056/NEJMc1904003
- Preventing Venous Thromboembolism in Patients with Cancer. Reply.N Engl J Med. 2019; 380: 2181https://doi.org/10.1056/NEJMc1904003
- Efficacy and safety of primary thromboprophylaxis for the prevention of venous thromboembolism in patients with cancer and a central venous catheter: a systematic review and meta-analysis.Thromb Res. 2021; 208: 58-65https://doi.org/10.1016/j.thromres.2021.10.012
Article info
Publication history
Published online: January 17, 2023
Accepted:
January 11,
2023
Received in revised form:
January 9,
2023
Received:
January 3,
2023
Publication stage
In Press Corrected ProofIdentification
Copyright
© 2023 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
